MetaCap

Nurix Therapeutics Statistics

NASDAQ: NRIXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.85-0.755 (-5.55%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Nurix Therapeutics by the numbers

Nurix Therapeutics has a market capitalization of $1.40 billion based on 109.25M shares outstanding. Its trailing P/E ratio is 5.3. The stock trades 41.8% below its 50-day average and 36.0% below its 200-day average.

Average daily trading volume is 2.47M shares, or about $31.8 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

NRIX valuation vs. peer median

NRIX compared with the median of 8 peer companies
MetricNRIXPeer medianDifference
Market cap$1.40B$1.41B-0%
Avg. volume2.47M821.59K+201%

Peer median across 8 companies: TYRA, ANAB, ADRX, SRPT, KLRA, RAPP, DMRA, QURE.

Valuation

Price / sales (latest FY)
16.71

Price and trading

Previous close
13.60
Open
13.40
Day range
12.83 – 13.67
52-week range
12.83 – 28.23
52-week change
-23.33%
Beta
—
Volume
2.43M

Dividends and events

Annual dividend
None
Next earnings date
Oct 12, 2026

Additional statistics

Market Cap
1.40B
Pe
5.29
Forward Pe
-10.07
Eps
2.43
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
28.23
Week52 Low
12.83
Avg Volume
2.47M
Shares Outstanding
109.25M
Ma50
22.07
Ma200
20.06
Earnings Date
Oct 12, 2026
Pct From52w High
-54.50%
Pct From52w Low
0.16%

Related